
|Videos|April 23, 2018
Intermediate-Risk Newly Diagnosed Metastatic Renal Cell Carcinoma
Intermediate-Risk Newly Diagnosed Metastatic Renal Cell Carcinoma
Advertisement
Case Scenario: A 52-year old male with mRCC
February 2018
- A 52-year old Caucasian man presented to his physician complaining of severe left-sided back pain
- Laboratory findings: mild anemia, otherwise WNL
- CT scan of the abdomen and pelvis showed a large left renal mass, several small lytic lesions in the lumbar and thoracic vertebrae, and a small pulmonary nodule
- The patient underwent cytoreductive nephrectomy
- Diagnosis; stage IV clear-cell renal cell carcinoma; good-risk
- He received radiation therapy to his spinal lesions and was then started on cabozantinib 60 mg daily
- The patient reported moderate nausea and vomiting and diarrhea after 6 weeks on therapy; he continues to do well with improved tolerance after dose adjustment to 40 mg
- Imaging at 3 months showed a significant decrease in size of the pulmonary nodule
Advertisement
Advertisement
Advertisement
Trending on Targeted Oncology - Immunotherapy, Biomarkers, and Cancer Pathways
1
The Targeted Pulse: Lung Cancer Advancements and FDA Decisions
2
Nivolumab Outperforms Brentuximab Vedotin in PFS in Classic Hodgkin Lymphoma
3
Savolitinib/Osimertinib Extends PFS in MET-Amplified EGFR-Mutated NSCLC
4
Second-Line Therapy and Ruxolitinib for cGVHD
5













































